These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24383421)

  • 21. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
    Hu Q; Bally MB; Madden TD
    Nucleic Acids Res; 2002 Aug; 30(16):3632-41. PubMed ID: 12177306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker.
    Geselowitz DA; Neckers LM
    Antisense Res Dev; 1992; 2(1):17-25. PubMed ID: 1422083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.
    Roth CM
    Biophys J; 2005 Oct; 89(4):2286-95. PubMed ID: 16055530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.
    Shi F; Nomden A; Oberle V; Engberts JB; Hoekstra D
    Nucleic Acids Res; 2001 May; 29(10):2079-87. PubMed ID: 11353077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin targeted delivery of gene therapeutics.
    Juliano RL; Ming X; Nakagawa O; Xu R; Yoo H
    Theranostics; 2011 Mar; 1():211-9. PubMed ID: 21547161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of antisense oligonucleotides and functional block of acetylcholine receptor subunit gene expression in primary embryonic neurons.
    Yu C; Brussaard AB; Yang X; Listerud M; Role LW
    Dev Genet; 1993; 14(4):296-304. PubMed ID: 7693387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocytosis and Degradation of Pegvisomant and a Potential New Mechanism That Inhibits the Nuclear Translocation of GHR.
    Lan H; Li W; Li R; Zheng X; Luo G
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1887-1899. PubMed ID: 30602026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanisms of Antisense Oligonucleotides.
    Crooke ST
    Nucleic Acid Ther; 2017 Apr; 27(2):70-77. PubMed ID: 28080221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid conjugated oligonucleotides: a useful strategy for delivery.
    Raouane M; Desmaële D; Urbinati G; Massaad-Massade L; Couvreur P
    Bioconjug Chem; 2012 Jun; 23(6):1091-104. PubMed ID: 22372953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the role of methacrylic acid copolymers in the intracellular delivery of antisense oligonucleotides.
    Yessine MA; Meier C; Petereit HU; Leroux JC
    Eur J Pharm Biopharm; 2006 May; 63(1):1-10. PubMed ID: 16364618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence of PEI and PAMAM Gene Delivery on Clathrin- and Caveolin-Dependent Trafficking Pathways.
    Hwang ME; Keswani RK; Pack DW
    Pharm Res; 2015 Jun; 32(6):2051-9. PubMed ID: 25511918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides.
    Wang S; Allen N; Vickers TA; Revenko AS; Sun H; Liang XH; Crooke ST
    Nucleic Acids Res; 2018 Apr; 46(7):3579-3594. PubMed ID: 29514240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covalent conjugation of oligonucleotides with cell-targeting ligands.
    Alam MR; Ming X; Nakagawa O; Jin J; Juliano RL
    Bioorg Med Chem; 2013 Oct; 21(20):6217-23. PubMed ID: 23777829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice.
    Kakiuchi-Kiyota S; Koza-Taylor PH; Mantena SR; Nelms LF; Enayetallah AE; Hollingshead BD; Burdick AD; Reed LA; Warneke JA; Whiteley LO; Ryan AM; Mathialagan N
    Toxicol Sci; 2014 Mar; 138(1):234-48. PubMed ID: 24336348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
    Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H
    Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
    Juliano RL
    Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor.
    Ming X; Alam MR; Fisher M; Yan Y; Chen X; Juliano RL
    Nucleic Acids Res; 2010 Oct; 38(19):6567-76. PubMed ID: 20551131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin.
    Lauvrak SU; Torgersen ML; Sandvig K
    J Cell Sci; 2004 May; 117(Pt 11):2321-31. PubMed ID: 15126632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
    Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
    Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.